Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated - PE Ratioverified

VRTX

Price:

$451.63

Market Cap:

$114.63B

Vertex Pharmaceuticals Incorporated is a leading biotechnology firm primarily focused on the discovery, advancement, and marketing of innovative treatments, particularly for cystic fibrosis (CF). The company offers a range of approved medications for CF patients, including SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO, which target specific mutations within the cystic fibrosis transmembrane conductance regulator gene. Additionally, they provide TRIKAFTA for individuals with CF aged six years and older who possess at least one F508del mutation. Beyond its established CF therapies, Vertex maintains a robust and diverse clinical pipeline. This includes VX-864, currently in Phase 2 for alpha-1 antitryp...[Read more]

Industry

Biotechnology

IPO Date

1991-07-24

Stock Exchange

NASDAQ

Ticker

VRTX

The PE Ratio as of June 2026 (TTM) for Vertex Pharmaceuticals Incorporated (VRTX) is 26.80

According to Vertex Pharmaceuticals Incorporated’s latest financial reports and current stock price. The company's current PE Ratio is 26.80. This represents a change of 4.65% compared to the average of 25.61 of the last 4 quarters.

Vertex Pharmaceuticals Incorporated (VRTX) Historical PE Ratio (quarterly & annually)

How has VRTX PE Ratio performed in the past?

The mean historical PE Ratio of Vertex Pharmaceuticals Incorporated over the last ten years is -1.71. The current 26.80 PE Ratio has changed -156437.31% with respect to the historical average. Over the past ten years (40 quarters), VRTX's PE Ratio was at its highest in in the June 2017 quarter at 460.25. The PE Ratio was at its lowest in in the September 2016 quarter at -128.25.

Quarterly (TTM)
Annual

Average

-1.71

Median

23.40

Minimum

-193.61

Maximum

141.38

Vertex Pharmaceuticals Incorporated (VRTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Vertex Pharmaceuticals Incorporated PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 195.28%

Maximum Annual PE Ratio = 141.38

Minimum Annual Increase = -768.52%

Minimum Annual PE Ratio = -193.61

Quarterly (TTM)
Annual
YearPE RatioChange
202529.32-115.15%
2024-193.61-768.52%
202328.9630.07%
202222.27-7.84%
202124.166.72%
202022.64-52.65%
201947.81138.00%
201820.09-85.79%
2017141.38-188.28%
2016-160.15195.28%

Vertex Pharmaceuticals Incorporated (VRTX) Average PE Ratio

How has VRTX PE Ratio performed in the past?

The current PE Ratio of Vertex Pharmaceuticals Incorporated (VRTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-45.11

5-year avg

-17.78

10-year avg

-1.71

Vertex Pharmaceuticals Incorporated (VRTX) PE Ratio vs. Peers

How is VRTX’s PE Ratio compared to its peers?

Vertex Pharmaceuticals Incorporated’s PE Ratio is greater than McKesson Corporation (19.43), greater than HCA Healthcare, Inc. (12.83), greater than Medtronic plc (21.16), greater than Sanofi (11.75), greater than Regeneron Pharmaceuticals, Inc. (14.34), greater than GSK plc (13.28), greater than Bristol-Myers Squibb Company (15.17), less than argenx SE (49.74), less than CVS Health Corporation (42.56), less than Stryker Corporation (35.26),

Build a custom stock screener for Vertex Pharmaceuticals Incorporated (VRTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vertex Pharmaceuticals Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vertex Pharmaceuticals Incorporated (VRTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vertex Pharmaceuticals Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Vertex Pharmaceuticals Incorporated's PE Ratio?

How is the PE Ratio calculated for Vertex Pharmaceuticals Incorporated (VRTX)?

What is the highest PE Ratio for Vertex Pharmaceuticals Incorporated (VRTX)?

What is the 3-year average PE Ratio for Vertex Pharmaceuticals Incorporated (VRTX)?

What is the 5-year average PE Ratio for Vertex Pharmaceuticals Incorporated (VRTX)?

How does the current PE Ratio for Vertex Pharmaceuticals Incorporated (VRTX) compare to its historical average?